3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Drug News -

Radiation may offer better way to make vaccines

Drug NewsJul 26, 06

Vaccines made with bacteria killed by gamma rays may be more effective than those made using standard heat or chemical inactivation, U.S. government researchers said on Wednesday.

Such vaccines do not have to be kept cold, the team at the University of California, San Diego, School of Medicine reported in the journal Immunity.

Dr. Sandip Datta and colleagues made a vaccine from Listeria monocytogenes bacteria, a common cause of food poisoning.

The Listeria were killed with gamma rays and the vaccine protected mice infected with live Listeria, unlike vaccines made with heat-killed bacteria.

“This advance is potentially of great importance in meeting the challenge of creating vaccines that are safe, effective and simple to manufacture and transport,” said Dr. Elias Zerhouni, head of the National Institutes of Health, which paid for the study.

“Although completely inactivated by the radiation, and thus unable to cause illness, irradiated bacterial pathogens evidently retain characteristics that prompt the immune system to mount a full-fledged defense,” Datta said in a statement.

Vaccines can be made in three ways—using an attenuated, or weakened, form of live bacteria or virus, using a killed germ, or using pieces of DNA from a bacteria or virus.

Most attenuated vaccines must be kept cold, but the UCSD researchers found that mice could be protected by vaccination with irradiated Listeria that had been freeze-dried into a powder.

This might mean that such vaccines could be used in hot places without electricity, the researchers said.

Vaccines often protect mice but not people so the idea must be tested more, the researchers noted.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  Findings point to an ‘off switch’ for drug resistance in cancer
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat
  Pfizer lung cancer drug beats chemo for previously untreated patients
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Gates Foundation awards Notre Dame $23 million for malaria, dengue studies
  Cancer drug protects against diabetes
  Malaria drug target raises hopes for new treatments

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site